Mediastinal signet-ring cell carcinoma of unknown primary: long-term survival by treatment with S-1, a novel derivative of 5-fluorouracil.
Kusakari
Chika
C
Soda
Hiroshi
H
Nakamura
Yoichi
Y
Yamaguchi
Hiroyuki
H
Kitazaki
Takeshi
T
Nakano
Hirofumi
H
Matsubara
Yuichi
Y
Hayashi
Tomayoshi
T
Nagasaki
Toshiya
T
Nagayasu
Takeshi
T
Kohno
Shigeru
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D018279:Carcinoma, Signet Ring Cell / Q000175:diagnosis / Q000188:drug therapy* / Q000532:radiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D004338:Drug Combinations; D006801:Humans; D000077146:Irinotecan; D008297:Male; D008479:Mediastinal Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000532:radiotherapy; D008875:Middle Aged; D010094:Oxonic Acid / Q000008:administration & dosage*; D005641:Tegafur / Q000008:administration & dosage*; D014057:Tomography, X-Ray Computed
D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid; D000077146:Irinotecan; D002945:Cisplatin; D002166:Camptothecin